Skip to main content
. 2009 Dec 14;25(1):91–97. doi: 10.1359/jbmr.090704

Table 2.

Causes of Death in Placebo‐ and Zoledronic Acid–Treated Patients

Zoledronic acid, N = 1054 Placebo, N = 1057 P valuea
All causes (%) 101 (9.6) 141 (13.3) 0.01
Cardiac 36 (3.4) 52 (4.9) 0.10
Infectious 18 (1.7) 14 (1.3) 0.48
Respiratory 13 (1.2) 22 (2.1) 0.17
Neoplasms 7 (0.7) 13 (1.2) 0.26
Cerebrovascular 10 (1.0) 11 (1.0) 1.00
Gastrointestinal 2 (0.2) 4 (0.4) 0.69
Cachexia/failure to thrive 1 (0.1) 1 (0.1) 1.00
Renal 1 (0.1) 3 (0.3) 0.62
Other vascular 3 (0.3) 3 (0.3) 1.00
a

P value based on Fisher's exact test.